title: Prevalence of diabetes mellitus among outpatients with severe mental disorders receiving atypical antipsychotic drugs.
abstract: BACKGROUND
  Recent studies have suggested that patients receiving atypical antipsychotic drugs are at increased risk for developing diabetes mellitus. The purpose of this study is to examine the prevalence of diabetes in a group of adults with schizophrenia and other severe mental disorders receiving atypical antipsychotic drugs within a community mental health center setting.
  
  
  METHODS
  A retrospective chart review was conducted on 436 outpatients receiving either atypical antipsychotic or decanoate antipsychotic drugs at a community mental health center. Diagnosis of diabetes was established through the presence of documentation in the medical record. Patients with a history of diabetes prior to age 18 years were excluded. Data were gathered from April 2001 through September 2002.
  
  
  RESULTS
  The mean (SD) age of patients was 42.5 (10.8) years, and 57.3% were men. Patients were 61.5% white, 31.8% black, 5.3% Hispanic, and 2.3% other. Seventeen percent of patients had a positive family history of diabetes. Point prevalence of diabetes was 14.2% for the entire group. Chi-square analysis for the group revealed significant effects of age (chi(2) = 16.514, p <.001), family history of diabetes (chi(2) = 27.128, p <.001), and gender (chi(2) = 14.114, p <.001). A trend was noted toward a higher prevalence of diabetes among patients receiving atypical drugs (15.2%) compared with those receiving decanoate drugs (6.3%) (chi(2) = 2.984, p =.078).
  
  
  CONCLUSIONS
  Prevalence of diabetes mellitus among outpatients with severe mental disorders receiving atypical antipsychotic drugs is substantially higher than that reported in the general population. Results of this study are limited by the retrospective methodology, which may underestimate actual prevalence by failing to detect undiagnosed cases.
authors.affiliation: Department of Psychiatry, University of Rochester Medical Center, Rochester, NY 14642, USA. Steve_Lamberti@urmc.rochester.edu
authors.forename: J Steven
authors.initials: JS
authors.lastname: Lamberti
authors.forename: John F
authors.initials: JF
authors.lastname: Crilly
authors.forename: Kumar
authors.initials: K
authors.lastname: Maharaj
authors.forename: David
authors.initials: D
authors.lastname: Olson
authors.forename: Karen
authors.initials: K
authors.lastname: Wiener
authors.forename: Stephen
authors.initials: S
authors.lastname: Dvorin
authors.forename: G Oana
authors.initials: GO
authors.lastname: Costea
authors.forename: Margaret P
authors.initials: MP
authors.lastname: Bushey
authors.forename: Marci B
authors.initials: MB
authors.lastname: Dietz
mesh_terms: D000293:Adolescent; D000328:Adult; D017677:Age Distribution; D000553:Ambulatory Care; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016009:Chi-Square Distribution; D003155:Community Mental Health Centers; D003920:Diabetes Mellitus / Q000139:chemically induced / Q000175:diagnosis / Q000453:epidemiology*; D005260:Female; D006801:Humans; D008297:Male; D008499:Medical Records / Q000706:statistics & numerical data; D008875:Middle Aged; D009518:New York / Q000453:epidemiology; D015995:Prevalence; D011618:Psychotic Disorders / Q000188:drug therapy*; D012189:Retrospective Studies; D012307:Risk Factors; D012559:Schizophrenia / Q000188:drug therapy*; D012720:Severity of Illness Index; D017678:Sex Distribution
chemical_list: D014150:Antipsychotic Agents